Clinical and Prognostic Implications of Pretreatment Albumin to C-Reactive Protein Ratio in Patients With Hepatocellular Carcinoma

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5747-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Significance of C-Reactive Protein-To-Prealbumin Ratio in Patients With Esophageal Cancer

Yonago Acta Medica
Medicine
2020English

C-Reactive Protein to Albumin Ratio Is a Prognostic Factor for Patients With cStage II/III Esophageal Squamous Cell Cancer

Diseases of the Esophagus
MedicineGastroenterology
2017English

Clinical Burden of C-Reactive Protein/Albumin Ratio Before Curative Surgery for Gastric Cancer Patients

Journal of the American College of Surgeons
Surgery
2017English

Relationship Between C-Reactive Protein to Albumin Ratio and Thrombus Burden in Patients With Acute Coronary Syndrome

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2019English

Ratio of C-Reactive Protein to Albumin Predicts Muscle Mass in Adult Patients Undergoing Hemodialysis

PLoS ONE
Multidisciplinary
2016English

Prognostic Value of the C‐reactive Protein to Albumin Ratio in Esophageal Cancer: A Systematic Review and Meta‐analysis

Kaohsiung Journal of Medical Sciences
Medicine
2019English

The Prognostic Role of Glasgow Prognostic Score and C-Reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2020English

Clinical Significance of Systemic Immune-Inflammation Index (SII) and C-Reactive Protein-To-Albumin Ratio (CAR) in Patients With Esophageal Cancer: A Meta-Analysis

Cancer Management and Research
Oncology
2019English

The Value of Preoperative Glasgow Prognostic Score and the C-Reactive Protein to Albumin Ratio as Prognostic Factors for Long-Term Survival in Pathological T1N0 Esophageal Squamous Cell Carcinoma

Journal of Cancer
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy